|
Report Date : |
20.08.2014 |
IDENTIFICATION DETAILS
|
Name : |
P.T. INTRALAB EKATAMA |
|
|
|
|
Registered Office : |
Komplek Bumi Menteng Asri, Jalan
Terapi Raya, No. AD2, Bogor, West Java |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
28.10.1995 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Importer and Distributor of Laboratory Equipment. |
|
|
|
|
No of Employees : |
26 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 01, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
Indonesia |
B1 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderate Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderate High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
INDONESIA - ECONOMIC OVERVIEW
Indonesia, a vast polyglot nation,
has grown strongly since 2010. During the global financial crisis, Indonesia
outperformed its regional neighbors and joined China and India as the only G20
members posting growth. The government has promoted fiscally conservative
policies, resulting in a debt-to-GDP ratio of less than 25% and historically
low rates of inflation. Fitch and Moody's upgraded Indonesia's credit rating to
investment grade in December 2011. Indonesia still struggles with poverty and
unemployment, inadequate infrastructure, corruption, a complex regulatory
environment, and unequal resource distribution among regions. The government
also faces the challenges of quelling labor unrest and reducing fuel subsidies
in the face of high oil prices.
|
Source
: CIA |
Name of Company
P.T. INTRALAB
EKATAMA
Head Office
Komplek Bumi Menteng Asri
Jalan
Terapi Raya, No. AD2
Bogor,
West Java
Indonesia
Phones -
(62-251) 831 1662, 835 9110
F a x -
(62-251) 831 5710
Email - intralab@indo.net.id
Building Area - 2 storey
Office Space - 240 sq. meters
Region - Commercial
Status - Rent
Date of
Incorporation :
28 October 1995
Legal Form :
PT. (Perseroan Terbatas) or Limited
Liability Company
Company Reg. No. :
The Ministry of
Law and Human Right
a. No.
C2-5112.HT.01.01.TH’96
Dated
06 March 1996
b. No. C-7714.HT.01.04.TH.99
Dated
26 April 1999
c. No. AHU-94416.AH.01.02.Tahun 2008
Dated
09 December 2008
Company Status :
National Private Company
Permit by the
Government Department :
The Department of
Finance
NPWP No. 01.633.139.9-404.000
Not Available
Capital Structure
:
Authorized Capital - Rp. 500,000,000.-
Issued Capital - Rp. 300,000,000.-
Paid up Capital - Rp. 300,000,000.-
Shareholders/Owners
:
a. Mr. Drs. Unggul Santika - Rp. 195,000,000.- (65%)
Address : Pinang
Mas VI/Q-18
RT. 012/003, Pondok Pinang
Jakarta Selatan
Indonesia
b. Mr. Dr. Listriono Prayitno, SE - Rp. 15,000,000.-
(5%)
Address : Griya
Indah Bogor Blok G, No. 09
RT. 002/014, Kedung
Bogor, West Java
Indonesia
c. Ms. Gwat Kwi Makmur - Rp.
15,000,000.- (5%)
Address : Taman
Alfa Indah B2, No. 16
RT. 016/005, Joglo
Jakarta Barat
Indonesia
d. Mr. Budy Sulistriono, SS - Rp. 75,000,000.- (25%)
Address : Jalan
Medika III C/AN 31
RT. 003/019, Menteng
Bogor, West Java
Indonesia
Lines of Business
:
Importer and Distributor of Laboratory
Equipments
Production
Capacity :
None
Total Investment :
None
Started Operation
:
1996
Brand Name :
INTRALAB EKATAMA
Technical
Assistance :
None
Number of Employee
:
26 Persons
Marketing Area :
Local -
100%
Main Customers :
a. Food
and Beverage Industries
b. Pharmaceutical
Industries
c. Cosmetic
Industries
d. Other
industries research needs in the country
Market Situation :
Competitive
Main Competitors :
a. P.T.
INDOKEMIKA JAYATAMA
b. P.T.
DOW CHEMICAL INDONESIA
c. P.T.
CIPTA PRIMA CHEMINDO
d. P.T.
MAKMUR JAYA KHARISMA
e. Etc.
Business Trend :
Growing
Bankers :
a.
P.T.
BANK DANAMON INDONESIA Tbk
Jalan Ir. H. Juanda No. 46
Bogor, West Java
Indonesia
b P.T. BANK CENTRAL ASIA Tbk
Jalan
Ir. H. Juanda No. 28
Bogor, West Java
Indonesia
Auditor :
Internal Auditor
Litigation :
No litigation record in our database
Annual Sales
(estimated) :
2011 – Rp. 61.0 billion
2012 – Rp. 70.0 billion
2013 – Rp. 82.0 billion
Net Profit
(estimated) :
2011 – Rp. 3.3 billion
2012 – Rp. 3.8 billion
2013 – Rp. 4.5 billion
Payment Manner :
Almost promptly
Financial Comments
:
Satisfactory
Board of
Management :
Director - Mr. Budy Sulistriono, SS
Board of Commissioner :
Commissioner - Mr. Dr. Listriono Prayitno, SE
Signatories
:
The
Director (Mr. Budy
Sulistriono, SS) which must be approved by the Board of Commissioner
(Mr. Dr. Listriono Prayitno, SE)
Management
Capability :
G o o d
Business Morality
:
G o o d
Credit Risk :
Below average
P.T. INTRALAB EKATAMA (P.T. IE) was established
in Bogor (West Java) based on Notarial Deed No. 319 dated March 06, 1996 made
by Notary Hasnah Sari, SH., with an authorized capital of Rp. 500,000,000.- of
which Rp 240,000,000.- was issued and fully paid up. The founding shareholders
of the company are Mr. Drs. Unggul Santika (65%), Mr. Dr. Listriono Prayitno,
SE (5%), Ms. Gwat Kwi Makmur (5%) and Mr. Budi Sulistriono, SS (25%). The Deed
of establishment has been approved by the Minister of Law and Human Rights of
the Republic of Indonesia through its Decision Letter No.
C2—5112.HT.01.01.TH’96 dated March 06, 1996.
The articles of association of the company
have frequently been changed, most recently by notarial Deed No. 01 dated
December 09, 2008 made by Notary Mirna Karmila Ananta, SH., with an authorized
capital same as previously authorized capital
to Rp. 500,000,000.- of which Rp 300,000,000.- was
issued and fully paid up. The latest shareholders of the company are Mr. Drs.
Unggul Santika (65%), Mr. Dr. Listriono Prayitno, SE (5%), Ms. Gwat Kwi Makmur
(5%) and Mr. Budi Sulistriono, SS (25%). The amendment to Deed has been
approved by the Minister of Law and Human Rights through its Decision Letter
No. AHU-94416.AH.01.02.Tahun 2008 dated December
09, 2008. No changes have been effected in term of its shareholding composition
and capital structures to date.
P.T. IE engaged in importer and distributor
of laboratory equipments. Its head office is located on Komplek Bumi Menteng
Asri, Jalan Terapi Raya AD2, Bogor (West Java) on a office space of
some 420 sq. meters. Mr. Budi Sulistriono, SS, a director of the company
explained that P.T. IE as agent for the products are imported from several
countries such as America (Axygen and Corning), Malaysia (Vivantis) and others
laboratory equipments. The products are marketed locally to research the needs
of the food and beverage industries, pharmaceutical industries, cosmetic
industries and other industries research needs in the country. We observed that
P.T. IE is classified as a medium sized company of its kind in the country of
which the operation has been growing in the last three years.
We note that generally the domestic demand
for laboratory equipments has been rising by about 6% - 8% on the average per
annum in the last five years in line with the rapid growth of various
industrial sectors including food and beverage industries, pharmaceutical
industries, cosmetic industries and other industries research needs in the
country. But later dwindled as the global economic slowdown since October 2008
, followed by tight money policy imposed by Indonesian Central Bank and also
heated by political issue in the country. The demand growth started to awake in
June 2009 in liner the amelioration of economic condition in the country.
Market competition is very tough on account of large number of other similar
companies operating in the country. P.T. IE business position in this case is
not too badly because it has built regular customers and extensive marketing
network all across the country. The demand of laboratory equipments is
projected to go on rising each year in the next three years.
The company is neither public listed nor
bond issued company. Therefore, the company has no obligation to publish
financial statement publicly. The
management is very reclusive and unlikely to expose its financial condition to
outsider. We estimate that sales turnover of the company in 2011
amounted to Rp. 61.0 billion increased to Rp. 70.0 billion in 2012 and rose
again to Rp. 82.0 billion in 2013. The operation of the company in 2013 yielded
a net profit at least Rp. 4.5 billion and the company has a total net worth of
Rp. 1.2 billion. It is projected that total sales turnover of the company will
increase at least 8% in 2014. So far we did not hear that P.T. IE has been
black listed by Bank Indonesia (Central Bank) or having detrimental cases being
settled in local district court. The company usually pays its debts punctually
to suppliers.
The management of P.T. IE is led by Mr. Budy
Sulistriono, SS (46) as director, a businessman with experience for more 15
years in importer and distributor of laboratory equipments. In his daily
activities, he is assisted by Mr. Dr. Listriono, SE (49). The management has
maintained a wide relation with private businessmen at home and abroad as well
as with government authorities. So far,
we did not hear that the company's management having been involved in the
business malpractices.
P.T. IE is appraised to be good for business
transaction. However, in view of the
economic condition in the country is still unstable, we recommend to treat
prudently in extending any new loan to the company.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.73 |
|
|
1 |
Rs.101.47 |
|
Euro |
1 |
Rs.81.04 |
INFORMATION DETAILS
|
Analysis Done by
: |
SUM |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation
is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.